First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis.
Thierry LandreKader ChouahniaGaëtan Des GuetzBoris DuchemannJean-Baptiste AssiéChristos ChouaidPublished in: Therapeutic advances in medical oncology (2020)
First-line ICI+CT appears to be superior to CT alone for ES-SCLC except for patients with brain metastases at diagnosis.